Takeda Pharmaceutical Company Limited (TAK) has 12 identified peers for comparison in the Healthcare sector. Peers include A, ALC, AMPH, BDX, BHC, CAH and others.
TAK has a market capitalization of $56.39B, compared to an average peer market cap of $17.53B. TAK is significantly larger than its average peer.
